Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Engineered T Cells market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Engineered T Cellsmarket, defines the market attractiveness level of Engineered T Cells market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Engineered T Cells industry, describes the types of Engineered T Cells market, the applications of major players and the market size, and deeply analyzes the current situation of the global Engineered T Cells market and the development prospects and opportunities of Engineered T Cells industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Engineered T Cells market in Chapter 13.
By Player:
Juno Therapeutics
Unum Therapeutics
Gilead Sciences
Bellicum Pharmaceuticals
Pfizer
Redmile Group
Oxford Biomedica
Elli Lilly and Company
Cells Medica
Seeking Alpha
Autolus Limited
Precision Bioscience
Novartis
By Type:
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
By End-User:
Hospitals
Cancer Research Centers
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Engineered T Cells Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Engineered T Cells Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Engineered T Cells Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Engineered T Cells Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Engineered T Cells Market Analysis and Outlook to 2022
-
7.1 Global Engineered T Cells Consumption (2017-2022)
-
7.2 United States Engineered T Cells Consumption (2017-2022)
-
7.3 Europe Engineered T Cells Consumption (2017-2022)
-
7.4 China Engineered T Cells Consumption (2017-2022)
-
7.5 Japan Engineered T Cells Consumption (2017-2022)
-
7.6 India Engineered T Cells Consumption (2017-2022)
-
7.7 South Korea Engineered T Cells Consumption (2017-2022)
8 Region and Country-wise Engineered T Cells Market Analysis and Outlook to 2028
-
8.1 Global Engineered T Cells Consumption Forecast (2022-2028)
-
8.2 United States Engineered T Cells Consumption Forecast (2022-2028)
-
8.3 Europe Engineered T Cells Consumption Forecast (2022-2028)
-
8.4 China Engineered T Cells Consumption Forecast (2022-2028)
-
8.5 Japan Engineered T Cells Consumption Forecast (2022-2028)
-
8.6 India Engineered T Cells Consumption Forecast (2022-2028)
-
8.7 South Korea Engineered T Cells Consumption Forecast (2022-2028)
9 Global Engineered T Cells Market Outlook by Types and Applications to 2022
-
9.1 Global Engineered T Cells Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tumor Infiltrating Lymphocytes Consumption and Growth Rate (2017-2022)
-
9.1.2 Global T Cell Receptor {TCR} Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Chimeric Antigen Receptor (CAR) Consumption and Growth Rate (2017-2022)
-
9.2 Global Engineered T Cells Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Engineered T Cells Market Outlook by Types and Applications to 2028
-
10.1 Global Engineered T Cells Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tumor Infiltrating Lymphocytes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global T Cell Receptor {TCR} Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Chimeric Antigen Receptor (CAR) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Engineered T Cells Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Engineered T Cells Import and Export Analysis (Top 5 Countries)
-
11.1 Global Engineered T Cells Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Engineered T Cells Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Engineered T Cells Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Engineered T Cells Market Competitive Analysis
-
14.1 Juno Therapeutics
-
14.1.1 Juno Therapeutics Company Details
-
14.1.2 Juno Therapeutics Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Juno Therapeutics Engineered T Cells Product and Service
-
14.2 Unum Therapeutics
-
14.2.1 Unum Therapeutics Company Details
-
14.2.2 Unum Therapeutics Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Unum Therapeutics Engineered T Cells Product and Service
-
14.3 Gilead Sciences
-
14.3.1 Gilead Sciences Company Details
-
14.3.2 Gilead Sciences Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gilead Sciences Engineered T Cells Product and Service
-
14.4 Bellicum Pharmaceuticals
-
14.4.1 Bellicum Pharmaceuticals Company Details
-
14.4.2 Bellicum Pharmaceuticals Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bellicum Pharmaceuticals Engineered T Cells Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Engineered T Cells Product and Service
-
14.6 Redmile Group
-
14.6.1 Redmile Group Company Details
-
14.6.2 Redmile Group Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Redmile Group Engineered T Cells Product and Service
-
14.7 Oxford Biomedica
-
14.7.1 Oxford Biomedica Company Details
-
14.7.2 Oxford Biomedica Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Oxford Biomedica Engineered T Cells Product and Service
-
14.8 Elli Lilly and Company
-
14.8.1 Elli Lilly and Company Company Details
-
14.8.2 Elli Lilly and Company Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Elli Lilly and Company Engineered T Cells Product and Service
-
14.9 Cells Medica
-
14.9.1 Cells Medica Company Details
-
14.9.2 Cells Medica Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Cells Medica Engineered T Cells Product and Service
-
14.10 Seeking Alpha
-
14.10.1 Seeking Alpha Company Details
-
14.10.2 Seeking Alpha Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Seeking Alpha Engineered T Cells Product and Service
-
14.11 Autolus Limited
-
14.11.1 Autolus Limited Company Details
-
14.11.2 Autolus Limited Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Autolus Limited Engineered T Cells Product and Service
-
14.12 Precision Bioscience
-
14.12.1 Precision Bioscience Company Details
-
14.12.2 Precision Bioscience Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Precision Bioscience Engineered T Cells Product and Service
-
14.13 Novartis
-
14.13.1 Novartis Company Details
-
14.13.2 Novartis Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novartis Engineered T Cells Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Engineered T Cells
-
Figure Engineered T Cells Picture
-
Table Global Engineered T Cells Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Engineered T Cells Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Engineered T Cells Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Engineered T Cells Consumption by Country (2017-2022)
-
Figure United States Engineered T Cells Consumption and Growth Rate (2017-2022)
-
Table Europe Engineered T Cells Consumption and Growth Rate (2017-2022)
-
Figure China Engineered T Cells Consumption and Growth Rate (2017-2022)
-
Figure Japan Engineered T Cells Consumption and Growth Rate (2017-2022)
-
Figure India Engineered T Cells Consumption and Growth Rate (2017-2022)
-
Figure South Korea Engineered T Cells Consumption and Growth Rate (2017-2022)
-
Figure Global Engineered T Cells Consumption Forecast by Country (2022-2028)
-
Figure United States Engineered T Cells Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Engineered T Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Engineered T Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Engineered T Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Engineered T Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Engineered T Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor Infiltrating Lymphocytes Consumption and Growth Rate (2017-2022)
-
Figure Global T Cell Receptor {TCR} Consumption and Growth Rate (2017-2022)
-
Figure Global Chimeric Antigen Receptor (CAR) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Infiltrating Lymphocytes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global T Cell Receptor {TCR} Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chimeric Antigen Receptor (CAR) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Engineered T Cells Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Engineered T Cells Export by Region (Top 5 Countries) (2017-2028)
-
Table Juno Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Juno Therapeutics Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics Engineered T Cells Product and Service
-
Table Unum Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Unum Therapeutics Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unum Therapeutics Engineered T Cells Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Engineered T Cells Product and Service
-
Table Bellicum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Bellicum Pharmaceuticals Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bellicum Pharmaceuticals Engineered T Cells Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Engineered T Cells Product and Service
-
Table Redmile Group (Foundation Year, Company Profile and etc.)
-
Table Redmile Group Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Redmile Group Engineered T Cells Product and Service
-
Table Oxford Biomedica (Foundation Year, Company Profile and etc.)
-
Table Oxford Biomedica Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford Biomedica Engineered T Cells Product and Service
-
Table Elli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Elli Lilly and Company Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elli Lilly and Company Engineered T Cells Product and Service
-
Table Cells Medica (Foundation Year, Company Profile and etc.)
-
Table Cells Medica Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cells Medica Engineered T Cells Product and Service
-
Table Seeking Alpha (Foundation Year, Company Profile and etc.)
-
Table Seeking Alpha Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seeking Alpha Engineered T Cells Product and Service
-
Table Autolus Limited (Foundation Year, Company Profile and etc.)
-
Table Autolus Limited Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Autolus Limited Engineered T Cells Product and Service
-
Table Precision Bioscience (Foundation Year, Company Profile and etc.)
-
Table Precision Bioscience Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Precision Bioscience Engineered T Cells Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Engineered T Cells Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Engineered T Cells Product and Service
-
